Key result
Advances in reperfusion, antithrombotic therapies, and preventative measures over the past three decades have significantly reduced the incidence and mortality of acute myocardial infarction.
Advances in reperfusion, medical therapies, and preventative measures over the past three decades have significantly reduced the incidence and mortality of acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Improved MI survival underscores prevention priority; leaves open which strategies best reduce residual risk in contemporary cohorts.
The past three decades have witnessed major gains in outcomes of patients with acute myocardial infarction owed largely to the implementation of systems of care prioritising timely reperfusion, advances in antithrombotic and antiplatelet therapies, and the development of post-myocardial infarction heart failure therapies.1–5 Preventative measures like smoking cessation, adoption of healthy aerobic lifestyles, and intensified treatment of risk factors including hypertension, diabetes, and hypercholesterolaemia have further contributed to reducing the burden of atherosclerotic coronary artery disease and decreased the incidence of age-adjusted myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Reed et al. (2022) conducted a review in Acute myocardial infarction. Advances in reperfusion, antithrombotic therapies, and preventative measures over the past three decades have significantly reduced the incidence and mortality of acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: